DENTSPLY SIRONA INC (XRAY) Fundamental Analysis & Valuation

NASDAQ:XRAY • US24906P1093

Current stock price

11.54 USD
+0.59 (+5.39%)
At close:
11.5 USD
-0.04 (-0.35%)
After Hours:

This XRAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. XRAY Profitability Analysis

1.1 Basic Checks

  • XRAY had positive earnings in the past year.
  • In the past year XRAY had a positive cash flow from operations.
  • In the past 5 years XRAY reported 4 times negative net income.
  • XRAY had a positive operating cash flow in each of the past 5 years.
XRAY Yearly Net Income VS EBIT VS OCF VS FCFXRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B -1.5B

1.2 Ratios

  • XRAY has a Return On Assets (-11.01%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -44.66%, XRAY is in line with its industry, outperforming 50.79% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 4.89%, XRAY is doing good in the industry, outperforming 75.66% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for XRAY is significantly below the industry average of 9.31%.
  • The last Return On Invested Capital (4.89%) for XRAY is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -11.01%
ROE -44.66%
ROIC 4.89%
ROA(3y)-9.54%
ROA(5y)-7.32%
ROE(3y)-31.84%
ROE(5y)-22.45%
ROIC(3y)4.23%
ROIC(5y)4.67%
XRAY Yearly ROA, ROE, ROICXRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • XRAY has a Operating Margin of 6.88%. This is in the better half of the industry: XRAY outperforms 72.49% of its industry peers.
  • XRAY's Operating Margin has declined in the last couple of years.
  • XRAY's Gross Margin of 50.00% is in line compared to the rest of the industry. XRAY outperforms 46.03% of its industry peers.
  • In the last couple of years the Gross Margin of XRAY has remained more or less at the same level.
Industry RankSector Rank
OM 6.88%
PM (TTM) N/A
GM 50%
OM growth 3Y-9.52%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.67%
GM growth 5Y-0.36%
XRAY Yearly Profit, Operating, Gross MarginsXRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. XRAY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XRAY is destroying value.
  • Compared to 1 year ago, XRAY has more shares outstanding
  • Compared to 5 years ago, XRAY has less shares outstanding
  • The debt/assets ratio for XRAY is higher compared to a year ago.
XRAY Yearly Shares OutstandingXRAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
XRAY Yearly Total Debt VS Total AssetsXRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.90, we must say that XRAY is in the distress zone and has some risk of bankruptcy.
  • XRAY has a Altman-Z score (0.90) which is comparable to the rest of the industry.
  • XRAY has a debt to FCF ratio of 22.38. This is a negative value and a sign of low solvency as XRAY would need 22.38 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 22.38, XRAY is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • XRAY has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.50, XRAY is doing worse than 78.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 22.38
Altman-Z 0.9
ROIC/WACC0.55
WACC8.94%
XRAY Yearly LT Debt VS Equity VS FCFXRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • XRAY has a Current Ratio of 1.51. This is a normal value and indicates that XRAY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of XRAY (1.51) is worse than 74.60% of its industry peers.
  • XRAY has a Quick Ratio of 1.03. This is a normal value and indicates that XRAY is financially healthy and should not expect problems in meeting its short term obligations.
  • XRAY's Quick ratio of 1.03 is on the low side compared to the rest of the industry. XRAY is outperformed by 77.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.03
XRAY Yearly Current Assets VS Current LiabilitesXRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. XRAY Growth Analysis

3.1 Past

  • The earnings per share for XRAY have decreased by -4.79% in the last year.
  • The Earnings Per Share has been decreasing by -2.34% on average over the past years.
  • The Revenue has decreased by -2.98% in the past year.
  • XRAY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.96% yearly.
EPS 1Y (TTM)-4.79%
EPS 3Y-8.57%
EPS 5Y-2.34%
EPS Q2Q%3.85%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-2.1%
Revenue growth 5Y1.96%
Sales Q2Q%6.19%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.14% on average over the next years.
  • Based on estimates for the next years, XRAY will show a small growth in Revenue. The Revenue will grow by 1.31% on average per year.
EPS Next Y-7.79%
EPS Next 2Y0.27%
EPS Next 3Y3.98%
EPS Next 5Y4.14%
Revenue Next Year-1.86%
Revenue Next 2Y0.09%
Revenue Next 3Y1.06%
Revenue Next 5Y1.31%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XRAY Yearly Revenue VS EstimatesXRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
XRAY Yearly EPS VS EstimatesXRAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. XRAY Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.26, the valuation of XRAY can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of XRAY indicates a rather cheap valuation: XRAY is cheaper than 96.30% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.54. XRAY is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 7.87 indicates a rather cheap valuation of XRAY.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of XRAY indicates a rather cheap valuation: XRAY is cheaper than 97.35% of the companies listed in the same industry.
  • XRAY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 7.26
Fwd PE 7.87
XRAY Price Earnings VS Forward Price EarningsXRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 97.35% of the companies in the same industry are more expensive than XRAY, based on the Enterprise Value to EBITDA ratio.
  • XRAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. XRAY is cheaper than 86.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.16
EV/EBITDA 6.92
XRAY Per share dataXRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.27%
EPS Next 3Y3.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. XRAY Dividend Analysis

5.1 Amount

  • XRAY has a Yearly Dividend Yield of 5.17%, which is a nice return.
  • XRAY's Dividend Yield is rather good when compared to the industry average which is at 0.24. XRAY pays more dividend than 99.47% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, XRAY pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.17%

5.2 History

  • On average, the dividend of XRAY grows each year by 9.95%, which is quite nice.
  • XRAY has paid a dividend for at least 10 years, which is a reliable track record.
  • XRAY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.95%
Div Incr Years6
Div Non Decr Years30
XRAY Yearly Dividends per shareXRAY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of XRAY are negative and hence is the payout ratio. XRAY will probably not be able to sustain this dividend level.
  • The dividend of XRAY is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-21.4%
EPS Next 2Y0.27%
EPS Next 3Y3.98%
XRAY Yearly Income VS Free CF VS DividendXRAY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B -1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

XRAY Fundamentals: All Metrics, Ratios and Statistics

DENTSPLY SIRONA INC

NASDAQ:XRAY (3/23/2026, 8:25:08 PM)

After market: 11.5 -0.04 (-0.35%)

11.54

+0.59 (+5.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners104.18%
Inst Owner Change-3.83%
Ins Owners0.22%
Ins Owner Change5.44%
Market Cap2.31B
Revenue(TTM)3.68B
Net Income(TTM)-598.00M
Analysts70
Price Target13.22 (14.56%)
Short Float %6.53%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 5.17%
Yearly Dividend0.64
Dividend Growth(5Y)9.95%
DP-21.4%
Div Incr Years6
Div Non Decr Years30
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.91%
Min EPS beat(2)-19.03%
Max EPS beat(2)-4.78%
EPS beat(4)2
Avg EPS beat(4)5.76%
Min EPS beat(4)-19.03%
Max EPS beat(4)45.37%
EPS beat(8)3
Avg EPS beat(8)-2.22%
EPS beat(12)5
Avg EPS beat(12)0.84%
EPS beat(16)7
Avg EPS beat(16)2.02%
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)-1.16%
Max Revenue beat(2)1.63%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.43%
Revenue beat(12)5
Avg Revenue beat(12)-0.96%
Revenue beat(16)6
Avg Revenue beat(16)-1.46%
PT rev (1m)1.68%
PT rev (3m)1.83%
EPS NQ rev (1m)-21.49%
EPS NQ rev (3m)-23.01%
EPS NY rev (1m)-5.83%
EPS NY rev (3m)-9.18%
Revenue NQ rev (1m)-5.92%
Revenue NQ rev (3m)-5.8%
Revenue NY rev (1m)-2.54%
Revenue NY rev (3m)-2.59%
Valuation
Industry RankSector Rank
PE 7.26
Fwd PE 7.87
P/S 0.63
P/FCF 22.16
P/OCF 9.81
P/B 1.72
P/tB N/A
EV/EBITDA 6.92
EPS(TTM)1.59
EY13.78%
EPS(NY)1.47
Fwd EY12.71%
FCF(TTM)0.52
FCFY4.51%
OCF(TTM)1.18
OCFY10.19%
SpS18.42
BVpS6.7
TBVpS-3.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number15.49
Profitability
Industry RankSector Rank
ROA -11.01%
ROE -44.66%
ROCE 6.19%
ROIC 4.89%
ROICexc 5.32%
ROICexgc 12.2%
OM 6.88%
PM (TTM) N/A
GM 50%
FCFM 2.83%
ROA(3y)-9.54%
ROA(5y)-7.32%
ROE(3y)-31.84%
ROE(5y)-22.45%
ROIC(3y)4.23%
ROIC(5y)4.67%
ROICexc(3y)4.53%
ROICexc(5y)4.96%
ROICexgc(3y)13.19%
ROICexgc(5y)19.09%
ROCE(3y)5.56%
ROCE(5y)6.04%
ROICexgc growth 3Y-15.1%
ROICexgc growth 5Y-11.06%
ROICexc growth 3Y3.36%
ROICexc growth 5Y12.36%
OM growth 3Y-9.52%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.67%
GM growth 5Y-0.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 22.38
Debt/EBITDA 3.33
Cap/Depr 37.22%
Cap/Sales 3.56%
Interest Coverage 3.83
Cash Conversion 38.84%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.03
Altman-Z 0.9
F-Score5
WACC8.94%
ROIC/WACC0.55
Cap/Depr(3y)44.08%
Cap/Depr(5y)43.74%
Cap/Sales(3y)4.02%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.79%
EPS 3Y-8.57%
EPS 5Y-2.34%
EPS Q2Q%3.85%
EPS Next Y-7.79%
EPS Next 2Y0.27%
EPS Next 3Y3.98%
EPS Next 5Y4.14%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-2.1%
Revenue growth 5Y1.96%
Sales Q2Q%6.19%
Revenue Next Year-1.86%
Revenue Next 2Y0.09%
Revenue Next 3Y1.06%
Revenue Next 5Y1.31%
EBIT growth 1Y10%
EBIT growth 3Y-11.42%
EBIT growth 5Y-1.8%
EBIT Next Year18.41%
EBIT Next 3Y10.01%
EBIT Next 5Y10.04%
FCF growth 1Y-62.99%
FCF growth 3Y-34.38%
FCF growth 5Y-28.64%
OCF growth 1Y-49.02%
OCF growth 3Y-23.11%
OCF growth 5Y-18.39%

DENTSPLY SIRONA INC / XRAY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DENTSPLY SIRONA INC (XRAY) stock?

ChartMill assigns a fundamental rating of 4 / 10 to XRAY.


What is the valuation status for XRAY stock?

ChartMill assigns a valuation rating of 7 / 10 to DENTSPLY SIRONA INC (XRAY). This can be considered as Undervalued.


How profitable is DENTSPLY SIRONA INC (XRAY) stock?

DENTSPLY SIRONA INC (XRAY) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for XRAY stock?

The Price/Earnings (PE) ratio for DENTSPLY SIRONA INC (XRAY) is 7.26 and the Price/Book (PB) ratio is 1.72.


Can you provide the dividend sustainability for XRAY stock?

The dividend rating of DENTSPLY SIRONA INC (XRAY) is 7 / 10 and the dividend payout ratio is -21.4%.